These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 11851742)
21. Upper limb corticomotor projections and physiological changes that occur with botulinum toxin-A therapy in children with hemiplegic cerebral palsy. Redman TA; Gibson N; Finn JC; Bremner AP; Valentine J; Thickbroom GW Eur J Neurol; 2008 Aug; 15(8):787-91. PubMed ID: 18684310 [TBL] [Abstract][Full Text] [Related]
22. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy. Crowner BE; Racette BA Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363 [TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin A in the management of upper limb spasticity in cerebral palsy. Chin TY; Graham HK Hand Clin; 2003 Nov; 19(4):591-600. PubMed ID: 14596551 [TBL] [Abstract][Full Text] [Related]
24. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study. Franzén M; Hägglund G; Alriksson-Schmidt A BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927 [TBL] [Abstract][Full Text] [Related]
25. Upper-limb injections of botulinum toxin-A in children with cerebral palsy: a critical review of the literature and clinical implications for occupational therapists. Hoare BJ; Imms C Am J Occup Ther; 2004; 58(4):389-97. PubMed ID: 15315245 [TBL] [Abstract][Full Text] [Related]
26. Modified constraint-induced movement therapy or bimanual occupational therapy following injection of Botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: a randomised controlled trial methods paper. Hoare BJ; Imms C; Rawicki HB; Carey L BMC Neurol; 2010 Jul; 10():58. PubMed ID: 20602795 [TBL] [Abstract][Full Text] [Related]
27. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children]. Dohin B; Garin C; Vanhems P; Kohler R Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878 [TBL] [Abstract][Full Text] [Related]
28. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study. Buyukavci R; Akturk S; Ersoy Y Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486 [TBL] [Abstract][Full Text] [Related]
29. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy. Intiso D; Simone V; Di Rienzo F; Iarossi A; Pazienza L; Santamato A; Maruzzi G; Basciani M NeuroRehabilitation; 2014; 34(3):515-22. PubMed ID: 24473245 [TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity. Kawamura A; Campbell K; Lam-Damji S; Fehlings D Dev Med Child Neurol; 2007 May; 49(5):331-7. PubMed ID: 17489805 [TBL] [Abstract][Full Text] [Related]
31. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection. Park ES; Park CI; Kim DY; Kim YR Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331 [TBL] [Abstract][Full Text] [Related]
32. Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: preliminary report. Suputtitada A Am J Phys Med Rehabil; 2000; 79(4):320-6. PubMed ID: 10892617 [TBL] [Abstract][Full Text] [Related]
33. Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review. García Salazar LF; dos Santos GL; Pavão SL; Rocha NA; de Russo TL Dev Neurorehabil; 2015 Feb; 18(1):1-14. PubMed ID: 25180438 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of Botulinum Toxin Type A Injection Followed by Rehabilitation in Cases of Cerebral Palsy With Upper Extremity Involvement. Karaca B; Ünlü E; Köse G; Gönen E; Çakcı A J Child Neurol; 2016 Mar; 31(3):357-63. PubMed ID: 26239492 [TBL] [Abstract][Full Text] [Related]
35. A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia. Ferrari A; Maoret AR; Muzzini S; Alboresi S; Lombardi F; Sgandurra G; Paolicelli PB; Sicola E; Cioni G Res Dev Disabil; 2014 Oct; 35(10):2505-13. PubMed ID: 24995688 [TBL] [Abstract][Full Text] [Related]
36. Tendon transfer surgery in upper-extremity cerebral palsy is more effective than botulinum toxin injections or regular, ongoing therapy. Van Heest AE; Bagley A; Molitor F; James MA J Bone Joint Surg Am; 2015 Apr; 97(7):529-36. PubMed ID: 25834076 [TBL] [Abstract][Full Text] [Related]
37. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength. Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803 [TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006 [TBL] [Abstract][Full Text] [Related]
39. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study. Lin YC; Lin IL; Chou TF; Lee HM J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526 [TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin type A management of spasticity in the context of orthopaedic surgery for children with spastic cerebral palsy. Graham HK Eur J Neurol; 2001 Nov; 8 Suppl 5():30-9. PubMed ID: 11851732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]